IONS logo

Ionis Pharmaceuticals (IONS) Net income

annual net income:

-$453.90M-$87.61M(-23.92%)
December 31, 2024

Summary

  • As of today (May 29, 2025), IONS annual net profit is -$453.90 million, with the most recent change of -$87.61 million (-23.92%) on December 31, 2024.
  • During the last 3 years, IONS annual net income has fallen by -$425.30 million (-1487.22%).
  • IONS annual net income is now -263.19% below its all-time high of $278.14 million, reached on December 31, 2019.

Performance

IONS Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

quarterly net income:

-$146.94M-$42.59M(-40.81%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS quarterly net profit is -$146.94 million, with the most recent change of -$42.59 million (-40.81%) on March 31, 2025.
  • Over the past year, IONS quarterly net income has dropped by -$4.13 million (-2.90%).
  • IONS quarterly net income is now -145.91% below its all-time high of $320.08 million, reached on December 31, 2018.

Performance

IONS quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

TTM net income:

-$458.03M-$4.13M(-0.91%)
March 31, 2025

Summary

  • As of today (May 29, 2025), IONS TTM net profit is -$458.03 million, with the most recent change of -$4.13 million (-0.91%) on March 31, 2025.
  • Over the past year, IONS TTM net income has dropped by -$73.27 million (-19.04%).
  • IONS TTM net income is now -206.57% below its all-time high of $429.81 million, reached on September 30, 2019.

Performance

IONS TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIONSincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

IONS Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-23.9%-2.9%-19.0%
3 y3 years-1487.2%-125.5%-10000.0%
5 y5 years-263.2%-270.8%-397.3%

IONS Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-1487.2%at low-1486.3%+0.3%-6356.4%at low
5 y5-year-263.2%at low-165.4%+58.5%-397.3%+24.6%
alltimeall time-263.2%at low-145.9%+58.5%-206.6%+24.6%

IONS Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$146.94M(+40.8%)
-$458.03M(+0.9%)
Dec 2024
-$453.90M(+23.9%)
-$104.35M(-25.7%)
-$453.90M(+26.5%)
Sep 2024
-
-$140.48M(+112.0%)
-$358.81M(-1.9%)
Jun 2024
-
-$66.27M(-53.6%)
-$365.74M(-4.9%)
Mar 2024
-
-$142.80M(+1441.6%)
-$384.77M(+5.0%)
Dec 2023
-$366.29M(+35.8%)
-$9.26M(-93.7%)
-$366.29M(-10.5%)
Sep 2023
-
-$147.41M(+72.8%)
-$409.45M(+32.5%)
Jun 2023
-
-$85.29M(-31.4%)
-$309.04M(-6.0%)
Mar 2023
-
-$124.32M(+137.1%)
-$328.88M(+21.9%)
Dec 2022
-$269.72M(+843.2%)
-$52.43M(+11.6%)
-$269.72M(-3784.2%)
Sep 2022
-
-$46.99M(-55.3%)
$7.32M(-126.0%)
Jun 2022
-
-$105.14M(+61.3%)
-$28.15M(+623.2%)
Mar 2022
-
-$65.17M(-129.0%)
-$3.89M(-86.4%)
Dec 2021
-$28.60M(-93.6%)
$224.61M(-372.4%)
-$28.60M(-95.3%)
Sep 2021
-
-$82.47M(+2.0%)
-$607.74M(+10.6%)
Jun 2021
-
-$80.88M(-10.0%)
-$549.74M(+11.2%)
Mar 2021
-
-$89.87M(-74.7%)
-$494.50M(+11.3%)
Dec 2020
-$444.26M(-259.7%)
-$354.53M(+1349.0%)
-$444.26M(-664.6%)
Sep 2020
-
-$24.47M(-4.6%)
$78.68M(-39.2%)
Jun 2020
-
-$25.64M(-35.3%)
$129.31M(-16.1%)
Mar 2020
-
-$39.63M(-123.5%)
$154.07M(-44.6%)
Dec 2019
$278.14M(+1.6%)
$168.41M(+543.7%)
$278.14M(-35.3%)
Sep 2019
-
$26.16M(-3086.6%)
$429.81M(+7.7%)
Jun 2019
-
-$876.00K(-101.0%)
$399.08M(+11.0%)
Mar 2019
-
$84.44M(-73.6%)
$359.61M(+31.4%)
Dec 2018
$273.74M(>+9900.0%)
$320.08M(-7120.8%)
$273.74M(-655.8%)
Sep 2018
-
-$4.56M(-88.7%)
-$49.25M(+4.1%)
Jun 2018
-
-$40.35M(+2741.9%)
-$47.31M(+371.4%)
Mar 2018
-
-$1.42M(-51.4%)
-$10.04M(-2983.9%)
Dec 2017
$346.00K(-100.6%)
-$2.92M(+11.8%)
$348.00K(-99.4%)
Sep 2017
-
-$2.61M(-15.4%)
$55.29M(-15.3%)
Jun 2017
-
-$3.08M(-134.4%)
$65.25M(+468.3%)
Mar 2017
-
$8.96M(-82.8%)
$11.48M(-119.0%)
Dec 2016
-$60.40M(-31.6%)
$52.02M(+607.7%)
-$60.40M(-67.1%)
Sep 2016
-
$7.35M(-112.9%)
-$183.85M(-19.0%)
Jun 2016
-
-$56.85M(-9.6%)
-$226.98M(+68.8%)
Mar 2016
-
-$62.92M(-11.9%)
-$134.48M(+52.3%)
Dec 2015
-$88.28M(+126.4%)
-$71.43M(+99.7%)
-$88.28M(-721.3%)
Sep 2015
-
-$35.78M(-200.4%)
$14.21M(-39.0%)
Jun 2015
-
$35.65M(-313.2%)
$23.31M(-195.4%)
Mar 2015
-
-$16.72M(-153.8%)
-$24.42M(-37.4%)
Dec 2014
-$38.98M(-35.7%)
$31.05M(-216.4%)
-$38.98M(-58.7%)
Sep 2014
-
-$26.68M(+120.8%)
-$94.31M(+2.3%)
Jun 2014
-
-$12.08M(-61.4%)
-$92.21M(+2.2%)
Mar 2014
-
-$31.28M(+28.9%)
-$90.25M(+48.8%)
Dec 2013
-$60.64M(-7.4%)
-$24.28M(-1.2%)
-$60.64M(+55.5%)
Sep 2013
-
-$24.57M(+142.6%)
-$39.01M(-25.1%)
Jun 2013
-
-$10.13M(+505.6%)
-$52.07M(+20.7%)
Mar 2013
-
-$1.67M(-36.6%)
-$43.16M(-34.1%)
Dec 2012
-$65.48M(-22.8%)
-$2.64M(-93.0%)
-$65.48M(-21.0%)
Sep 2012
-
-$37.64M(+3018.4%)
-$82.88M(+14.9%)
Jun 2012
-
-$1.21M(-95.0%)
-$72.12M(-18.8%)
Mar 2012
-
-$24.00M(+19.8%)
-$88.80M(+4.7%)
Dec 2011
-$84.80M(+38.4%)
-$20.04M(-25.5%)
-$84.80M(+7.7%)
Sep 2011
-
-$26.88M(+50.3%)
-$78.75M(+22.4%)
Jun 2011
-
-$17.89M(-10.5%)
-$64.32M(-10.1%)
Mar 2011
-
-$19.99M(+43.0%)
-$71.59M(+16.9%)
Dec 2010
-$61.25M(-139.5%)
-$13.99M(+12.3%)
-$61.25M(-4.5%)
Sep 2010
-
-$12.45M(-50.5%)
-$64.11M(+1.4%)
Jun 2010
-
-$25.15M(+160.4%)
-$63.23M(+54.9%)
Mar 2010
-
-$9.66M(-42.6%)
-$40.81M(-126.3%)
Dec 2009
$155.07M(-953.3%)
-$16.84M(+45.4%)
$155.07M(-4.1%)
Sep 2009
-
-$11.58M(+324.2%)
$161.64M(-7.5%)
Jun 2009
-
-$2.73M(-101.5%)
$174.84M(+0.6%)
Mar 2009
-
$186.22M(-1914.6%)
$173.83M(-1056.6%)
Dec 2008
-$18.17M(+65.3%)
-$10.26M(-736.2%)
-$18.17M(+22.2%)
Sep 2008
-
$1.61M(-143.2%)
-$14.87M(-521.5%)
Jun 2008
-
-$3.74M(-35.4%)
$3.53M(-193.8%)
Mar 2008
-
-$5.79M(-16.8%)
-$3.76M(-65.8%)
Dec 2007
-$10.99M
-$6.96M(-134.8%)
-$10.99M(-39.5%)
DateAnnualQuarterlyTTM
Sep 2007
-
$20.01M(-281.5%)
-$18.18M(-63.8%)
Jun 2007
-
-$11.02M(-15.3%)
-$50.30M(+21.4%)
Mar 2007
-
-$13.02M(-8.0%)
-$41.44M(-9.7%)
Dec 2006
-$45.90M(-36.6%)
-$14.15M(+16.9%)
-$45.90M(+15.7%)
Sep 2006
-
-$12.11M(+457.3%)
-$39.67M(-7.2%)
Jun 2006
-
-$2.17M(-87.6%)
-$42.74M(-29.0%)
Mar 2006
-
-$17.48M(+120.9%)
-$60.22M(-16.8%)
Dec 2005
-$72.40M(-49.2%)
-$7.91M(-47.8%)
-$72.40M(-40.7%)
Sep 2005
-
-$15.17M(-22.8%)
-$122.03M(-12.6%)
Jun 2005
-
-$19.66M(-33.7%)
-$139.56M(-4.3%)
Mar 2005
-
-$29.66M(-48.5%)
-$145.85M(+2.4%)
Dec 2004
-$142.50M(+50.0%)
-$57.54M(+75.9%)
-$142.50M(+29.2%)
Sep 2004
-
-$32.71M(+26.0%)
-$110.34M(+10.5%)
Jun 2004
-
-$25.95M(-1.4%)
-$99.83M(+2.9%)
Mar 2004
-
-$26.31M(+3.7%)
-$96.98M(+2.1%)
Dec 2003
-$95.00M(+31.5%)
-$25.38M(+14.3%)
-$95.00M(+11.2%)
Sep 2003
-
-$22.20M(-3.9%)
-$85.45M(+5.7%)
Jun 2003
-
-$23.10M(-5.0%)
-$80.83M(+2.8%)
Mar 2003
-
-$24.32M(+53.7%)
-$78.59M(+8.8%)
Dec 2002
-$72.24M(-2.2%)
-$15.83M(-9.9%)
-$72.24M(+0.3%)
Sep 2002
-
-$17.58M(-15.8%)
-$72.04M(+7.9%)
Jun 2002
-
-$20.86M(+16.1%)
-$66.78M(-3.2%)
Mar 2002
-
-$17.97M(+15.0%)
-$68.96M(-6.6%)
Dec 2001
-$73.83M(+38.0%)
-$15.63M(+26.9%)
-$73.83M(+0.2%)
Sep 2001
-
-$12.32M(-46.5%)
-$73.65M(+10.3%)
Jun 2001
-
-$23.04M(+0.9%)
-$66.75M(+15.1%)
Mar 2001
-
-$22.85M(+47.9%)
-$58.01M(+8.5%)
Dec 2000
-$53.48M(-9.7%)
-$15.45M(+185.6%)
-$53.48M(-3.9%)
Sep 2000
-
-$5.41M(-62.2%)
-$55.64M(-11.2%)
Jun 2000
-
-$14.30M(-22.0%)
-$62.63M(-3.4%)
Mar 2000
-
-$18.33M(+4.1%)
-$64.83M(+9.7%)
Dec 1999
-$59.20M(+37.7%)
-$17.60M(+41.9%)
-$59.10M(+1.5%)
Sep 1999
-
-$12.40M(-24.8%)
-$58.20M(+24.4%)
Jun 1999
-
-$16.50M(+31.0%)
-$46.80M(+6.1%)
Mar 1999
-
-$12.60M(-24.6%)
-$44.10M(+2.6%)
Dec 1998
-$43.00M(+38.3%)
-$16.70M(+1570.0%)
-$43.00M(+15.6%)
Sep 1998
-
-$1.00M(-92.8%)
-$37.20M(-3.1%)
Jun 1998
-
-$13.80M(+20.0%)
-$38.40M(+12.9%)
Mar 1998
-
-$11.50M(+5.5%)
-$34.00M(+9.3%)
Dec 1997
-$31.10M(+17.4%)
-$10.90M(+395.5%)
-$31.10M(+9.9%)
Sep 1997
-
-$2.20M(-76.6%)
-$28.30M(-11.8%)
Jun 1997
-
-$9.40M(+9.3%)
-$32.10M(+7.0%)
Mar 1997
-
-$8.60M(+6.2%)
-$30.00M(+13.2%)
Dec 1996
-$26.50M(+11.8%)
-$8.10M(+35.0%)
-$26.50M(+12.8%)
Sep 1996
-
-$6.00M(-17.8%)
-$23.50M(-3.7%)
Jun 1996
-
-$7.30M(+43.1%)
-$24.40M(+6.1%)
Mar 1996
-
-$5.10M(0.0%)
-$23.00M(-3.4%)
Dec 1995
-$23.70M(+30.2%)
-$5.10M(-26.1%)
-$23.80M(-3.6%)
Sep 1995
-
-$6.90M(+16.9%)
-$24.70M(+6.5%)
Jun 1995
-
-$5.90M(0.0%)
-$23.20M(+3.6%)
Mar 1995
-
-$5.90M(-1.7%)
-$22.40M(+23.1%)
Dec 1994
-$18.20M(-4.7%)
-$6.00M(+11.1%)
-$18.20M(+8.3%)
Sep 1994
-
-$5.40M(+5.9%)
-$16.80M(+5.0%)
Jun 1994
-
-$5.10M(+200.0%)
-$16.00M(+1.9%)
Mar 1994
-
-$1.70M(-63.0%)
-$15.70M(-17.8%)
Dec 1993
-$19.10M(-2.1%)
-$4.60M(0.0%)
-$19.10M(-3.5%)
Sep 1993
-
-$4.60M(-4.2%)
-$19.80M(-1.5%)
Jun 1993
-
-$4.80M(-5.9%)
-$20.10M(+2.6%)
Mar 1993
-
-$5.10M(-3.8%)
-$19.60M(+0.5%)
Dec 1992
-$19.50M(+124.1%)
-$5.30M(+8.2%)
-$19.50M(+12.1%)
Sep 1992
-
-$4.90M(+14.0%)
-$17.40M(+16.8%)
Jun 1992
-
-$4.30M(-14.0%)
-$14.90M(+18.3%)
Mar 1992
-
-$5.00M(+56.3%)
-$12.60M(+44.8%)
Dec 1991
-$8.70M(+93.3%)
-$3.20M(+33.3%)
-$8.70M(+31.8%)
Sep 1991
-
-$2.40M(+20.0%)
-$6.60M(+24.5%)
Jun 1991
-
-$2.00M(+81.8%)
-$5.30M(+20.5%)
Mar 1991
-
-$1.10M(0.0%)
-$4.40M(0.0%)
Dec 1990
-$4.50M
-$1.10M(0.0%)
-$4.40M(+33.3%)
Sep 1990
-
-$1.10M(0.0%)
-$3.30M(+50.0%)
Jun 1990
-
-$1.10M(0.0%)
-$2.20M(+100.0%)
Mar 1990
-
-$1.10M
-$1.10M

FAQ

  • What is Ionis Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals annual net income year-on-year change?
  • What is Ionis Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals quarterly net income year-on-year change?
  • What is Ionis Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Ionis Pharmaceuticals?
  • What is Ionis Pharmaceuticals TTM net income year-on-year change?

What is Ionis Pharmaceuticals annual net profit?

The current annual net income of IONS is -$453.90M

What is the all time high annual net income for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high annual net profit is $278.14M

What is Ionis Pharmaceuticals annual net income year-on-year change?

Over the past year, IONS annual net profit has changed by -$87.61M (-23.92%)

What is Ionis Pharmaceuticals quarterly net profit?

The current quarterly net income of IONS is -$146.94M

What is the all time high quarterly net income for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high quarterly net profit is $320.08M

What is Ionis Pharmaceuticals quarterly net income year-on-year change?

Over the past year, IONS quarterly net profit has changed by -$4.13M (-2.90%)

What is Ionis Pharmaceuticals TTM net profit?

The current TTM net income of IONS is -$458.03M

What is the all time high TTM net income for Ionis Pharmaceuticals?

Ionis Pharmaceuticals all-time high TTM net profit is $429.81M

What is Ionis Pharmaceuticals TTM net income year-on-year change?

Over the past year, IONS TTM net profit has changed by -$73.27M (-19.04%)
On this page